Information Letter on Increlex® 10 mg/ml solution for injection (mecasermin, recombinant human IGF-1): Interruption in supply
2013.10.18
Active substance: mecasermin, recombinant human IGF-1
The company Ipsen Pharma GmbH is sending out information that as of immediately the medicinal product Increlex® 10 mg/ml solution for injection can no longer be supplied in Germany.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN